Literature DB >> 8115788

Artificial neural networks for cancer research: outcome prediction.

H B Burke1.   

Abstract

The use of artificial neural networks in biological and medical research has increased tremendously in the last few years. Artificial neural networks are being used in cancer research for image processing, the analysis of laboratory data for breast cancer diagnosis, the discovery of chemotherapeutic agents, and for cancer outcome prediction. A neural network generalizes from the input data to patterns inherent in the data, and its uses these patterns to make predictions or to classify. This paper explains how neural networks work, and it shows that a neural network is more accurate at predicting breast cancer patient outcome than the current staging system.

Entities:  

Mesh:

Year:  1994        PMID: 8115788     DOI: 10.1002/ssu.2980100111

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  5 in total

1.  Artificial neural networks: useful aid in diagnosing acute appendicitis.

Authors:  S G Prabhudesai; S Gould; S Rekhraj; P P Tekkis; G Glazer; P Ziprin
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

Review 2.  The backpropagation neural network--a Bayesian classifier. Introduction and applicability to pharmacokinetics.

Authors:  R J Erb
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

Review 3.  Artificial neural networks: a prospective tool for the analysis of psychiatric disorders.

Authors:  C A Galletly; C R Clark; A C McFarlane
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

4.  Assessing the effect of quantitative and qualitative predictors on gastric cancer individuals survival using hierarchical artificial neural network models.

Authors:  Zohreh Amiri; Kazem Mohammad; Mahmood Mahmoudi; Mahbubeh Parsaeian; Hojjat Zeraati
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

5.  Mass spectrometric analysis of cerebrospinal fluid protein for glioma and its clinical application.

Authors:  Jian Liu; Jiekai Yu; Hong Shen; Jianmin Zhang; Weiguo Liu; Zhe Chen; Shuda He; Shu Zheng
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.